TRT(SH:600085) Zheng Quan Ri Bao·2025-12-10 16:41Core Viewpoint - The company is launching a comprehensive action plan titled "Quality Improvement, Efficiency Enhancement, and Return to Investors" for 2025, marking a new starting point for innovation and quality development in response to stringent regulations and market challenges [2][6] Group 1: Action Plan and Objectives - The action plan emphasizes enhancing operational efficiency and investment value, with a focus on stabilizing investor returns as a key annual task [2] - The initiative is a response to regulatory advocacy and aims to create long-term value for shareholders through improved quality, efficiency, and scale [2] Group 2: Quality Control and Management - Quality is identified as the lifeline of the company, with strict quality risk management from the source of raw materials to ensure product safety and controllability [2] - The company promotes a "zero-defect" quality management system focusing on source control, process supervision, and risk management [2] Group 3: Strategic Development and Innovation - The company is advancing three major strategies: "Big Variety Strategy, Boutique Strategy, and High-Quality Development Strategy," while optimizing its product matrix [3] - Collaborations with research institutions and universities are being pursued to accelerate the development of innovative drugs and traditional Chinese medicine [3] Group 4: Digital Transformation and Sustainability - The company is embracing digital transformation across its entire supply chain, enhancing production efficiency and quality through smart manufacturing and digital management platforms [3] - A photovoltaic project at the company’s Yizhuang plant has achieved grid connection, indicating progress in green transformation efforts [3] Group 5: Marketing and Consumer Engagement - The company is leveraging new media to reach younger demographics through digital marketing strategies, combining online content with offline store activities to enhance consumer experience [4] - The focus has shifted from expansion to improving the quality of store operations, with strategies aimed at enhancing store profitability [5] Group 6: International Expansion and Collaboration - The company has obtained product licenses in Canada and Hong Kong, indicating successful international expansion efforts [5] - Strategic partnerships are being formed to promote traditional Chinese medicine in key markets along the Belt and Road Initiative [5] Group 7: Governance and Compliance - The company is committed to optimizing its governance structure and enhancing transparency to support quality improvement and efficiency [5] - Revisions to the company’s articles of association and governance systems are being made in line with new regulations to improve governance efficiency and risk management [5]